申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2021026179A1
公开(公告)日:2021-02-11
The present invention is directed to compounds of the formula (I) wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
本发明涉及公式(I)中所有取代基的化合物,如本文所定义,以及包括该发明化合物的药学上可接受的组合物,以及使用该组合物治疗各种疾病的方法。